These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9365841)
1. [Analysis of induction of MDR1 gene expression by anticancer chemotherapy in bladder cancer]. Nezasa S; Fujihiro S; Deguchi T; Kawada Y; Kawamoto S; Tamaki M; Yamada S; Okano M Hinyokika Kiyo; 1997 Sep; 43(9):629-36. PubMed ID: 9365841 [TBL] [Abstract][Full Text] [Related]
2. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers. Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949 [TBL] [Abstract][Full Text] [Related]
3. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Tada Y; Wada M; Kuroiwa K; Kinugawa N; Harada T; Nagayama J; Nakagawa M; Naito S; Kuwano M Clin Cancer Res; 2000 Dec; 6(12):4618-27. PubMed ID: 11156211 [TBL] [Abstract][Full Text] [Related]
4. Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Clifford SC; Thomas DJ; Neal DE; Lunec J Br J Cancer; 1994 Apr; 69(4):680-6. PubMed ID: 7908215 [TBL] [Abstract][Full Text] [Related]
5. [Expression of lung resistance-related protein gene in transitional cell carcinoma of the bladder]. Kong CZ; Zhu YY; Ma ZY; Liu DH; Zeng Y; Li ZL Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):118-21. PubMed ID: 15771821 [TBL] [Abstract][Full Text] [Related]
6. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
7. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response. Pu YS; Tsai TC; Cheng AL; Tsai CY; Tseng NF; Su IJ; Hsieh CY; Lai MK J Urol; 1996 Jul; 156(1):271-5. PubMed ID: 8648821 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin. Tada Y; Wada M; Migita T; Nagayama J; Hinoshita E; Mochida Y; Maehara Y; Tsuneyoshi M; Kuwano M; Naito S Int J Cancer; 2002 Apr; 98(4):630-5. PubMed ID: 11920626 [TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid. Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988 [TBL] [Abstract][Full Text] [Related]
11. MDR1 gene expression in primary and advanced breast cancer. Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063 [TBL] [Abstract][Full Text] [Related]
12. mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy. Wang CS; LaRue H; Fortin A; Gariépy G; Têtu B Breast Cancer Res Treat; 1997 Aug; 45(1):63-74. PubMed ID: 9285118 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of multidrug resistance gene expression in human osteosarcomas. Lee PD; Noble-Topham SE; Bell RS; Andrulis IL Br J Cancer; 1996 Oct; 74(7):1046-50. PubMed ID: 8855972 [TBL] [Abstract][Full Text] [Related]
14. Study of the prediction system for clinical response to M-VAC neoadjuvant chemotherapy for bladder cancer. Takata R; Obara W; Fujioka T Aktuelle Urol; 2010 Jan; 41 Suppl 1():S41-5. PubMed ID: 20094952 [TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells. Dönmez Y; Gündüz U Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614 [TBL] [Abstract][Full Text] [Related]
16. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma. Rioja J; Bandrés E; Rosell Costa D; Rincón A; López I; Zudaire Bergera JJ; García Foncillas J; Gil MJ; Panizo A; Plaza L; Rioja LA; Berián Polo JM BJU Int; 2011 Jun; 107(11):1833-8. PubMed ID: 20840328 [TBL] [Abstract][Full Text] [Related]
17. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA. Li Y; Wang Y Biochem Biophys Res Commun; 1997 Oct; 239(1):345-8. PubMed ID: 9345322 [TBL] [Abstract][Full Text] [Related]
18. Expression of lung resistance-related protein in transitional cell carcinoma of bladder. Zhu Y; Kong C; Zeng Y; Sun Z; Gao H Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma. Shang C; Guo Y; Zhang H; Xue YX Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446 [TBL] [Abstract][Full Text] [Related]
20. Clinical relationship between MDR1 gene and gallbladder cancer. Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]